Regeneron, UPenn to use gene therapy tools to deliver a COVID-19 antibody drug

Regeneron is investigating the possibility that its antibody-based treatment for COVID-19 – an infusible drug recently used to treat President Trump – may protect against coronavirus infections when given as a nasal spray.